The Australasian Leukaemia & Lymphoma Group (ALLG) is Australia and New Zealand’s only not-for-profit blood cancer clinical trial research group.

Driven by our purpose ‘Better treatments…Better lives’, the ALLG is committed to improving the treatment, lives and survival rates of patients with blood cancers through clinical trial conduct. Working collaboratively with blood cancer specialists locally and internationally, our impact is profound.

Learn more about us

Download the ALLG Annual Review 2020

ALLG has had a positive financial year. This success is due to our strong partnerships and collaborations. In particular, we thank our members and patients and look forward to more trials creating better treatments and better lives.

ALLG 2020 Annual Review

Memberships

Our membership includes more than 700 blood cancer specialists who are united by a common goal to find better ways to treat blood cancers through clinical trial conduct.

Become an ALLG Member

Donations

Help make a difference to the life of someone who has blood cancer. For patients and their loved ones, your donation means an improved chance of cure and better quality of life.

Make a Donation

Clinical Trials & Research

Gain access to cutting-edge, potentially life-saving new treatments before they’re widely available to the public. Many people with cancer are now living longer, with a better quality of life, due to clinical trials.

Participate in a Clinical Trial

"The drugs and protocols offered to patients during clinical trials come at no cost and participation in trials for some patients may give them opportunities and hope, that may not have been accessible otherwise. Participation in a Clinical Trial also means regular and careful attention from Health Professionals in addition to the care offered by your own Specialist."

Anne Hodgson

Acute Myeloid Leukaemia survivor

"On 1 March 2001 I underwent a Bone Marrow Transplant. As a former cancer patient who underwent a clinical trial, I now see it as my job to promote, engage and encourage access to cancer research and clinical trials."

John Stubbs

Leukaemia survivor

“If I had acute myeloid leukaemia (AML) 30 years earlier it would have been a death sentence, but research has made survival not only possible but has improved survivors’ quality of life. Hopefully in another 30 years’ time a blood cancer diagnosis will just be a minor inconvenience.”

Pam K

Acute Myeloid Leukaemia survivor

"Life is good, and I am living it, but now I feel like I need to give something back. I've been doing some fundraising and a little public speaking for Lymphoma Australia, which has led me into ALLG where I am hoping I can do some more good work and help others get through it a little easier than I did."

Steve Towell

Mantle Cell Lymphoma survivor

"As a passionate advocate for people living with leukaemia, I look forward to serving as a consumer representative with ALLG, to assist in providing patients with opportunities to participate in clinical trials, which ultimately helps improve access to new medications for others afflicted with blood cancers."

Nathalie Cook

Myeloproliferative Neoplasm survivor

READ OUR SURVIVOR STORIES